Equianalgesic doses of opioids - their use in clinical practice.

Br J Pain

South Devon Healthcare NHS Foundation Trust, Torbay Hopsital, Torquay, UK.

Published: February 2012

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590088PMC
http://dx.doi.org/10.1177/2049463712437628DOI Listing

Publication Analysis

Top Keywords

equianalgesic doses
4
doses opioids
4
opioids clinical
4
clinical practice
4
equianalgesic
1
opioids
1
clinical
1
practice
1

Similar Publications

Purpose: Opioids are frequently used to treat pain in neonatal intensive care units (NICU) with fentanyl, morphine and sufentanil being mainly used agents. Equianalgesic potency between opioids is not clearly described in the neonatal population. The aim of this study was to compare theoretical and actual equipotent conversion ratios between morphine, sufentanil and fentanyl based on prescriptions.

View Article and Find Full Text PDF

New insights in the mechanisms of opioid analgesia and tolerance: Ultramicronized palmitoylethanolamide down-modulates vascular endothelial growth factor-A in the nervous system.

Pharmacol Res

November 2024

Department of Neuroscience, Psychology, DrugResearch and Child Health - NEUROFARBA - Section of Pharmacology andToxicology, University of Florence, Viale Pieraccini 6, Florence 50139, Italy.

Article Synopsis
  • Growing evidence shows that opioid analgesics, like morphine, can affect blood vessel formation (angiogenesis), which is linked to pain.
  • The study tested the effects of N-palmitoylethanolamine (PEA) and the anti-VEGF-A drug bevacizumab on morphine tolerance and pain relief, finding that PEA delays tolerance and enhances pain relief by reducing VEGF-A levels in the nervous system.
  • Both PEA and bevacizumab, when used with morphine, not only improved pain management but also decreased the expression of pain-related genes, suggesting a potential new approach to pain treatment that targets angiogenesis.
View Article and Find Full Text PDF

Standardizing opioid management is challenging due to the absence of a ceiling dose, the unknown ideal therapeutic plasma level, and the lack of an clear relationship between dose and therapeutic response. Opioid rotation or conversion, which is switching from one opioid, route of administration, or both, to another, to improve therapeutic response and reduce toxicities, occurs in 20-40 percent of patients treated with opioids. Opioid conversion is often needed when there are adverse effects, toxicities, or inability to tolerate a certain opioid formulation.

View Article and Find Full Text PDF

Audience: The lecture and infographic are targeted towards Emergency Medicine physicians and residents.

Introduction: Pain is the most common presenting symptom in the emergency department.1 Various classes of medications are used to treat acute and chronic pain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!